John Sapp: Clinical Trials

2 trials sponsored by John Sapp, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow John Sapp: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
Antiarrythmic Drug Therapy, Catheter ablation - Ventricular Tachycardia (VT)
Phase 4CompletedJohn Sapp4162016-10-012024-08-01
Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
Catheter Ablation, Escalated Antiarrhythmic Therapy - Recurrent Ventricular Tachycardia
Phase 4CompletedJohn Sapp2602009-05-012016-07-11

Conditions studied

Myocardial Ischemia (2)  ·  Tachycardia, Ventricular (2)

Interventions

Amiodarone (2)  ·  Catheter Ablation (2)  ·  Sotalol (1)

Countries

Canada (2)  ·  France (1)  ·  United States (1)

Top investigators

William G Stevenson, MD (2)  ·  Anthony L Tang, MD FRCPC (1)  ·  Anthony S Tang, MSc, MD, FRCPC (1)  ·  George A Wells, BSc MSc PhD (1)  ·  George A Wells, BSc,MSc,PhD (1)  ·  Jeff Healey, MD FRCPC (1)  ·  John L Sapp, BSc, MD, FRCPC (1)  ·  John L Sapp, MD FRCPC (1)  ·  Ratika Parkash, MD MSc FRCPC (1)  ·  Ratika Parkash, MD, MSc, FRCPC (1)

Results publications

PMID 27149033, PMID 29305400, PMID 31698933, PMID 38649085, PMID 39555820, PMID 41217320